Healthcare

Funds collected $408.6bn during H1 2024, up from $374.6bn for the same period last year, according to PEI data.

US states are piling more pressure onto private equity healthcare teams. Plus: a new Vitruvian man; and Carlyle co-founder David Rubenstein has come into some liquidity. Here's today's brief, for our valued subscribers only.

IK Partners' Frances Houweling, Partners Group's Jean Ghabache, and Bain Capital's Paul Moskowitz share their insight on the market's developments.

Healthcare-focused capital raising almost doubled last year as the average fund size soared.

As more capital becomes available to build on Europe’s long history of healthcare innovation, the market is gearing up for the next stage of growth, say Geraldine O’Keeffe and Dr Mark Braganza at EQT.

A growing middle class is one of several factors unlocking opportunities for innovative healthcare businesses – and PE firms are joining the gold rush.

Private equity firms can tap into shifting industry dynamics to generate value across their healthcare portfolios, say Deloitte Consulting’s Teresa Leste and Sagar Patel.

Tech enablement is having a transformative impact on the healthcare sector, helping to reduce costs and improve outcomes, says Permira principal Dimitrios Tzivelis.